What does this research mean for the field?

Somatic mutations, particularly clonal hematopoiesis of indeterminate potential (CHIP), are associated with an increased risk of cardiovascular disease and atherosclerosis progression, likely through the promotion of systemic inflammation. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To synthesize current evidence on the role of somatic mutations in blood and cardiovascular tissues, focusing on clonal hematopoiesis of indeterminate potential (CHIP) and its contribution to atherosclerosis.

August 26, 2026Vascular MedicineOpen Access

Clonal hematopoiesis of indeterminate potential (CHIP), vascular somatic mutation, and cardiovascular disease: A narrative review

View Full Paper

Ask AI

Bookmark

Authors

NPNicole Powell RCRichard M Cubbon MBMarc A Bailey

Discussion

Member takes

Overview

Narrative review reveals links between clonal hematopoiesis, vascular somatic mutations, and cardiovascular disease, highlighting pro-inflammatory mechanisms that accelerate atherosclerosis.

Key Points

To synthesize current evidence on the role of somatic mutations in blood and cardiovascular tissues, focusing on clonal hematopoiesis of indeterminate potential (CHIP) and its contribution to atherosclerosis.
Narrative review synthesizing genomic studies on next-generation sequencing in non-cancer tissues, hematopoietic stem cells, and vascular structures.
Evaluated mechanistic and observational data linking somatic clonal expansion to systemic inflammation, atherogenesis, and cardiovascular disease progression.
Somatic mutations in hematopoietic stem cells conferring survival advantages (CHIP) associate with elevated cardiovascular disease risk by promoting pro-inflammatory pathways that accelerate atherosclerosis.
Both CHIP and non-CHIP somatic mutations localize within atherosclerotic plaques, directly contributing to vascular remodeling and local atherogenesis.
Evidence demonstrates a bidirectional relationship where systemic inflammatory environments may also promote the emergence and expansion of CHIP clones.

Cite This Study

Powell et al. (2026) studied this question.

synapsesocial.com/papers/6a8e9b58451774b83f3b4145 https://doi.org/10.1177/1358863x261437058

View Full Paper

Ask AI

Bookmark

August 26, 2026Vascular MedicineOpen Access

Clonal hematopoiesis of indeterminate potential (CHIP), vascular somatic mutation, and cardiovascular disease: A narrative review

View Full Paper

Ask AI

Bookmark

Authors

NPNicole Powell RCRichard M Cubbon MBMarc A Bailey

Discussion

Member takes

Overview

Narrative review reveals links between clonal hematopoiesis, vascular somatic mutations, and cardiovascular disease, highlighting pro-inflammatory mechanisms that accelerate atherosclerosis.

Key Points

To synthesize current evidence on the role of somatic mutations in blood and cardiovascular tissues, focusing on clonal hematopoiesis of indeterminate potential (CHIP) and its contribution to atherosclerosis.
Narrative review synthesizing genomic studies on next-generation sequencing in non-cancer tissues, hematopoietic stem cells, and vascular structures.
Evaluated mechanistic and observational data linking somatic clonal expansion to systemic inflammation, atherogenesis, and cardiovascular disease progression.
Somatic mutations in hematopoietic stem cells conferring survival advantages (CHIP) associate with elevated cardiovascular disease risk by promoting pro-inflammatory pathways that accelerate atherosclerosis.
Both CHIP and non-CHIP somatic mutations localize within atherosclerotic plaques, directly contributing to vascular remodeling and local atherogenesis.
Evidence demonstrates a bidirectional relationship where systemic inflammatory environments may also promote the emergence and expansion of CHIP clones.

Cite This Study

Powell et al. (2026) studied this question.

synapsesocial.com/papers/6a8e9b58451774b83f3b4145 https://doi.org/10.1177/1358863x261437058

View Full Paper

Ask AI

Bookmark